Vildagliptin in New Onset Diabetes After Transplantation - A Double-blind, Randomized, Placebo-controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms VINODAT
- 10 Jun 2017 Biomarkers information updated
- 26 Nov 2013 Results published in the American Journal of Transplantation.
- 11 Sep 2013 Primary endpoint 'Glycaemic-control' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History